PROSION

Type6 Therapeutics

This deep-tech company develops kinase inhibitors for cancer treatment, intercepting enzymes in their inactive states to address drug resistance for patients with aggressive tumours.

Proteinea

This deep-tech company develops molecular biological medicines for the healthcare industry.

Tubulis

This deep-tech company develops antibody-drug conjugates to treat patients with solid tumours.

ProtOS

This company develops artificial intelligence models to design de-novo proteins for the degradation of undruggable targets for the pharmaceutical and medical biotechnology industries.

Phost'in Therapeutics

This deep-tech company develops small molecule glycocalyx modifiers to treat patients with aggressive solid tumours by restoring immune responses against cancer cells.

Circle Pharma

This deep-tech company develops macrocycle-based therapies to treat cancer and other serious illnesses for patients requiring targeted medical treatments.

A-Alpha Bio

This deep-tech company provides protein interaction data and predictive models to pharmaceutical firms for the discovery and engineering of new medicines.

Leash Bio

This deep-tech company generates large-scale biochemical datasets and machine learning models to assist biopharmaceutical partners and internal teams in designing new medicinal drugs.